News
Subtle differences in an mRNA sequence enables a ribosome to produce more or less of a certain protein. A new AI model called ...
The model can be accessed through Latent’s web-based platform for push-button protein design. Sign ups are open now for early access: platform.latentlabs.com Extensive lab validation shows picomolar ...
Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
Berkeley scientists have developed a smartphone-based biosensor that mimics coffee-ring physics to detect disease proteins ...
Traditional therapeutic antibody development has been constrained by long screening processes, and de novo antibody design requires a deep understanding of how the entire protein sequence affects ...
SAN FRANCISCO, June 30, 2025--Chai Discovery, which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules, today announced a breakthrough in ...
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the clinic faster.
Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results